Raltegravir Plus Abacavir/Lamivudine: Effective HIV-1 Switch Therapy in Virologically Suppressed Patients
Raltegravir combined with abacavir/lamivudine is a safe and well tolerated switching strategy for patients with stable HIV-1 infection
Supervised injection sites offer intravenous drug users sanitized needles to inject illicit drugs already in their possession. The goal, in part, is to reduce HIV transmission resulting from needle sharing. ...
Older adolescents initiating antiretroviral therapy have a high risk for loss to follow-up.
Approximately 8% of first-time HIV screening tests are men who have sex with men.